These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
394 related articles for article (PubMed ID: 24162158)
1. Characterization of cell lines derived from breast cancers and normal mammary tissues for the study of the intrinsic molecular subtypes. Prat A; Karginova O; Parker JS; Fan C; He X; Bixby L; Harrell JC; Roman E; Adamo B; Troester M; Perou CM Breast Cancer Res Treat; 2013 Nov; 142(2):237-55. PubMed ID: 24162158 [TBL] [Abstract][Full Text] [Related]
2. Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer. Prat A; Parker JS; Karginova O; Fan C; Livasy C; Herschkowitz JI; He X; Perou CM Breast Cancer Res; 2010; 12(5):R68. PubMed ID: 20813035 [TBL] [Abstract][Full Text] [Related]
3. Epithelial and mesenchymal subpopulations within normal basal breast cell lines exhibit distinct stem cell/progenitor properties. Sarrio D; Franklin CK; Mackay A; Reis-Filho JS; Isacke CM Stem Cells; 2012 Feb; 30(2):292-303. PubMed ID: 22102611 [TBL] [Abstract][Full Text] [Related]
4. Tumor initiating but differentiated luminal-like breast cancer cells are highly invasive in the absence of basal-like activity. Kim J; Villadsen R; Sørlie T; Fogh L; Grønlund SZ; Fridriksdottir AJ; Kuhn I; Rank F; Wielenga VT; Solvang H; Edwards PA; Børresen-Dale AL; Rønnov-Jessen L; Bissell MJ; Petersen OW Proc Natl Acad Sci U S A; 2012 Apr; 109(16):6124-9. PubMed ID: 22454501 [TBL] [Abstract][Full Text] [Related]
5. STAT1-deficient mice spontaneously develop estrogen receptor α-positive luminal mammary carcinomas. Chan SR; Vermi W; Luo J; Lucini L; Rickert C; Fowler AM; Lonardi S; Arthur C; Young LJ; Levy DE; Welch MJ; Cardiff RD; Schreiber RD Breast Cancer Res; 2012 Jan; 14(1):R16. PubMed ID: 22264274 [TBL] [Abstract][Full Text] [Related]
6. Normal Breast-Derived Epithelial Cells with Luminal and Intrinsic Subtype-Enriched Gene Expression Document Interindividual Differences in Their Differentiation Cascade. Kumar B; Prasad M; Bhat-Nakshatri P; Anjanappa M; Kalra M; Marino N; Storniolo AM; Rao X; Liu S; Wan J; Liu Y; Nakshatri H Cancer Res; 2018 Sep; 78(17):5107-5123. PubMed ID: 29997232 [TBL] [Abstract][Full Text] [Related]
7. Targeted Pten deletion plus p53-R270H mutation in mouse mammary epithelium induces aggressive claudin-low and basal-like breast cancer. Wang S; Liu JC; Kim D; Datti A; Zacksenhaus E Breast Cancer Res; 2016 Jan; 18(1):9. PubMed ID: 26781438 [TBL] [Abstract][Full Text] [Related]
8. TOX3 is expressed in mammary ER(+) epithelial cells and regulates ER target genes in luminal breast cancer. Seksenyan A; Kadavallore A; Walts AE; de la Torre B; Berel D; Strom SP; Aliahmad P; Funari VA; Kaye J BMC Cancer; 2015 Jan; 15():22. PubMed ID: 25632947 [TBL] [Abstract][Full Text] [Related]
9. Characterizing the HER2/neu status and metastatic potential of breast cancer stem/progenitor cells. Pommier SJ; Quan GG; Christante D; Muller P; Newell AE; Olson SB; Diggs B; Muldoon L; Neuwelt E; Pommier RF Ann Surg Oncol; 2010 Feb; 17(2):613-23. PubMed ID: 19838757 [TBL] [Abstract][Full Text] [Related]
10. Identification of cellular and genetic drivers of breast cancer heterogeneity in genetically engineered mouse tumour models. Melchor L; Molyneux G; Mackay A; Magnay FA; Atienza M; Kendrick H; Nava-Rodrigues D; López-García MÁ; Milanezi F; Greenow K; Robertson D; Palacios J; Reis-Filho JS; Smalley MJ J Pathol; 2014 Jun; 233(2):124-37. PubMed ID: 24615332 [TBL] [Abstract][Full Text] [Related]
11. Phenotypic and functional characterisation of the luminal cell hierarchy of the mammary gland. Shehata M; Teschendorff A; Sharp G; Novcic N; Russell IA; Avril S; Prater M; Eirew P; Caldas C; Watson CJ; Stingl J Breast Cancer Res; 2012 Oct; 14(5):R134. PubMed ID: 23088371 [TBL] [Abstract][Full Text] [Related]
12. Functional heterogeneity within the CD44 high human breast cancer stem cell-like compartment reveals a gene signature predictive of distant metastasis. Leth-Larsen R; Terp MG; Christensen AG; Elias D; Kühlwein T; Jensen ON; Petersen OW; Ditzel HJ Mol Med; 2012 Sep; 18(1):1109-21. PubMed ID: 22692575 [TBL] [Abstract][Full Text] [Related]
13. Claudin-low breast cancers: clinical, pathological, molecular and prognostic characterization. Sabatier R; Finetti P; Guille A; Adelaide J; Chaffanet M; Viens P; Birnbaum D; Bertucci F Mol Cancer; 2014 Oct; 13():228. PubMed ID: 25277734 [TBL] [Abstract][Full Text] [Related]